Esperion Therapeutics, Inc. drugs

2 results
  • nexletol - bempedoic acid tablet, film coated

    (Bempedoic Acid)
    Esperion Therapeutics, Inc.
    Nexletol reduces the risk of major cardiovascular events (heart attack, stroke, cardiovascular death) in adults unable to take statins, and lowers LDL cholesterol in adults with hypercholesterolemia, including heterozygous familial hypercholesterolemia, alone or with other cholesterol-lowering therapies.
  • nexlizet - bempedoic acid and ezetimibe tablet, film coated

    (Bempedoic Acid And Ezetimibe)
    Esperion Therapeutics, Inc.
    Nexlizet (bempedoic acid/ezetimibe) reduces LDL-C in adults with hypercholesterolemia, including heterozygous familial hypercholesterolemia, as an adjunct to diet and exercise. It also lowers the risk of cardiovascular death, heart attack, stroke, or coronary revascularization in adults at increased risk who cannot take recommended statin therapy.